Table 1.
The basic information of 190 donors in this research for clinical verification
N ame | P rimer sequence |
---|---|
hsa-miR-155 | Forward 5’-ACGCTCAGTTAATGCTAATCGTGATA-3’ |
Reverse 5’-ATTCCATGTTGTCCACTGTCTCTG-3’ | |
hsa-miR-29b-1* | Forward 5’-GGGTAGCACCATTTGAAATC-3’ |
Reverse 5’-TTTGGCACTAGCACATT-3’ | |
hsa-miR-150 | Forward 5’-TAGACGCGTCCGCGAGAGA-3’ |
Reverse 5’-GTGCAGGGTCCGAGGT-3 | |
hsa-miR-146a | Forward 5’-ACACTCCAGCTGGGTGAGAACTGAATTCCATG-3’ |
Reverse 5’-TGTCGTGGAGTCGGCAATTC-3’ | |
hsa-miR-212 | Forward 5’-GCGCTGGAATGTAAAGAAGT-3’ |
Reverse 5’-GTGCAGGGTCCGAGGT-3’ | |
hsa-miR-483-5p | Forward 5’-ACACTCCAGCTGGGAAGACGGGAGGAAAGAA-3’ |
Reverse 5’-CTCAACTGGTGTCGTGGA-3’ |
F: female; M: male